G. Taraboletti et al., INHIBITION OF ANGIOGENESIS AND MURINE HEMANGIOMA GROWTH BY BATIMASTAT, A SYNTHETIC INHIBITOR OF MATRIX METALLOPROTEINASES, Journal of the National Cancer Institute, 87(4), 1995, pp. 293-298
Background: The importance of matrix metalloproteinases in angiogenesi
s, tumor growth, and metastasis is well known. However, little is know
n about the role of matrix metalloproteinases in the formation of hema
ngiomas and about the possible therapeutic use of matrix metalloprotei
nase inhibitors in aggressive vascular tumors. Purpose: To study the r
ole of matrix metalloproteinase in vascular tumors, we tested the anti
neoplastic activity of a synthetic inhibitor of matrix metalloproteina
ses, batimastat, on an experimental model of hemangioma, formed by mur
ine endothelioma cells transformed by polyoma middle-T oncogene (eEnd.
1). Methods: The effect of batimastat was studied in vivo on the forma
tion of hemorrhaging, cavernous hemangiomas by eEnd.1 endothelioma cel
ls injected subcutaneously in nude mice and on the angiogenic response
induced by an endothelioma cell supernatant embedded in a pellet of r
econstituted basement membrane (Matrigel). The effect of batimastat wa
s investigated in vitro on endothelial cell proliferation, motility, a
nd invasion of a layer of Matrigel. Results: Daily treatment with bati
mastat (30, 3, and 0.3 mg/kg at the site of eEnd.1 cell injection) inh
ibited tumor growth, with increased doubling time. The carboxamide der
ivative of batimastat, BB-374, a poor inhibitor of matrix metalloprote
inase activity, was less active in reducing hemangioma growth. Histolo
gic analysis of treated tumors indicated a reduction in the size of bl
ood-filled spaces and in hemorrhage. Batimastat also inhibited the ang
iogenic response induced by cultured eEnd.1 endothelioma cell supernat
ant embedded in a pellet of Matrigel. Batimastat significantly inhibit
ed endothelial cell invasion in vitro through a layer of Matrigel, but
it showed no direct cytotoxic activity. Conclusions: Batimastat reduc
es in vivo growth of experimental hemangiomas, most probably by blocki
ng endothelial cell recruitment by the transformed cells or by interfe
ring with cell organization in vascular structures. Implications: Thes
e results confirm the importance of matrix metalloproteinase in endoth
elial cell recruitment that occurs in angiogenesis and in the formatio
n of vascular tumors and suggest a therapeutic potential for synthetic
matrix metalloproteinase inhibitors.